The Effect of Diabetes Mellitus on Costs and Length of Stay in Patients with Peripheral Arterial Disease Undergoing Vascular Surgery

被引:45
|
作者
Malone, M. [1 ,2 ]
Lau, N. S. [2 ,3 ]
White, J. [1 ,2 ]
Novak, A.
Xuan, W. [2 ]
Iliopoulos, J. [2 ,4 ]
Crozier, J. [2 ,4 ]
Dickson, H. G. [2 ,5 ]
机构
[1] Liverpool Hosp, High Risk Foot Serv, Liverpool, NSW 2170, Australia
[2] Ingham Inst Appl Med Res, LIVE DIAB CRU, Liverpool, NSW, Australia
[3] Liverpool Hosp, Diabet & Endocrine Serv, Liverpool, NSW 2170, Australia
[4] Western Hlth, Diabet Foot Serv, Melbourne, Vic, Australia
[5] Liverpool Hosp, Liverpool, NSW 2170, Australia
关键词
Diabetes mellitus; Economics; Length of stay; Lower limb; Peripheral arterial disease; Vascular surgery; PREVALENCE; CARE; HYPERGLYCEMIA;
D O I
10.1016/j.ejvs.2014.07.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To determine the impact of diabetes mellitus (DM) and other comorbidities on length of stay (LOS) and costs in patients with peripheral arterial disease (PAD) admitted to a vascular surgical unit. Methods: A retrospective study was conducted between January 2011 and July 2012 at a tertiary referral hospital in Sydney. Demographic, laboratory, and operative data were obtained from the Australasian Vascular Audit database and hospital diagnostic-related group (DRG) reports. Patients with confirmed PAD with or without DM requiring hospital admission for a diagnosis of claudication, rest pain, ulcer/gangrene, and infection that required lower limb surgical intervention were included. Associations between LOS, surgical procedure, and DRG were explored. Results: Five hundred and sixty-eight admissions (492 patients) were identified: 292 admissions with PAD and 276 admissions with PAD in conjunction with DM (PADDM). Mean LOS for patients with PAD was 10 +/- 13.7 days compared with 15 +/- 8.2 days for PADDM (p<.01; 95% confidence interval 2.7-8.0). LOS and costs were greatest in patients with PADDM undergoing major amputation (37 +/- 3.7 days; US$42,236; p<.01). Analysis of variance indicated that the best predictors of LOS were the presence of DM, bypass surgery, amputation, chronic kidney disease (CKD) stage V, infection, and emergency admission. Over 18 months, the estimated total inpatient costs associated with lower limb intervention for PAD with and without DM amounted to US$7,598,597. People with DM incurred greater inpatient costs, averaging US$1,912 more per episode of admission and a total of US$528,029 over 18 months. Conclusion: The impact of diabetes as a comorbid condition in patients with PAD is significant, both clinically and economically. Factors that predict increased LOS in patients with PAD are DM, bypass surgery, amputation, CKD stage V, infection, and emergency admission. (C) 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:447 / 451
页数:5
相关论文
共 50 条
  • [1] Peripheral arterial disease in patients with diabetes mellitus
    Mowla, Ashkan
    Bahrami, Amir
    Dastgheib, Seyed Alireza
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (07) : 707 - 708
  • [2] Peripheral arterial disease in patients with diabetes mellitus
    Hamish, M.
    Gohel, M. S.
    Davies, A. H.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (10) : 570 - 574
  • [3] Muscle Mitochondrial Function in Patients with Type 2 Diabetes Mellitus and Peripheral Arterial Disease: Implications in Vascular Surgery
    Pedersen, B. L.
    Baekgaard, N.
    Quistorff, B.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2009, 38 (03) : 356 - 364
  • [4] The significance of peripheral arterial disease in patients with diabetes mellitus
    Diehm, C.
    Schwertfeger, M.
    Kirch, W.
    Pittrow, D.
    DIABETOLOGE, 2009, 5 (01): : 12 - 18
  • [5] Peripheral arterial disease in diabetes mellitus
    Schmitt, Volker H.
    Keller, Karsten
    Espinola-Klein, Christine
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (22) : 1433 - 1436
  • [6] Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR
    Palmerini, Tullio
    Saia, Francesco
    Kim, Won-Keun
    Renker, Matthias
    Iadanza, Alessandro
    Fineschi, Massimo
    Bruno, Antonio Giulio
    Ghetti, Gabriele
    Vanhaverbeke, Maarten
    Sondergaard, Lars
    De Backer, Ole
    Romagnoli, Enrico
    Burzotta, Francesco
    Trani, Carlo
    Adrichem, Rik
    Van Mieghem, Nicolas M.
    Nardi, Elena
    Chietera, Francesco
    Orzalkiewicz, Mateusz
    Tomii, Daijiro
    Pilgrim, Thomas
    Aranzulla, Tiziana Claudia
    Musumeci, Giuseppe
    Adam, Matti
    Meertens, Max M.
    Taglieri, Nevio
    Marrozzini, Cinzia
    Covarrubias, Hector Alfonso Alvarez
    Joner, Michael
    Nardi, Giulia
    Di Muro, Francesca Maria
    Di Mario, Carlo
    Loretz, Lucca
    Toggweiler, Stefan
    Gallitto, Enrico
    Gargiulo, Mauro
    Testa, Luca
    Bedogni, Francesco
    Berti, Sergio
    Ancona, Marco B.
    Montorfano, Matteo
    Leone, Alessandro
    Savini, Carlo
    Pacini, Davide
    Gmeiner, Jonas
    Braun, Daniel
    Nerla, Roberto
    Castriota, Fausto
    De Carlo, Marco
    Petronio, Anna Sonia
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (04) : 396 - 411
  • [7] Clinical factors associated with ultrashort length of stay in patients undergoing lower extremity bypass for peripheral arterial disease
    Radomski, Shannon N.
    Sorber, Rebecca
    Canner, Joseph K.
    Holscher, Courtenay M.
    Weaver, M. Libby
    Hicks, Caitlin W.
    Reifsnyder, Thomas
    JOURNAL OF VASCULAR SURGERY, 2024, 80 (04)
  • [8] Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery Disease
    Weissler, E. Hope
    Narcisse, Dennis, I
    Rymer, Jennifer A.
    Armstrong, Ehrin J.
    Secemsky, Eric
    Gray, William A.
    Mustapha, Jihad A.
    Adams, George L.
    Ansel, Gary M.
    Patel, Manesh R.
    Jones, W. Schuyler
    VASCULAR AND ENDOVASCULAR SURGERY, 2021, 55 (02) : 124 - 134
  • [9] The evaluation of cardiac and peripheral arterial disease in patients with diabetes mellitus
    Shen, Rhuna
    Wiegers, Susan E.
    Glaser, Ruchira
    ENDOCRINE RESEARCH, 2007, 32 (3-4) : 109 - 142
  • [10] Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus
    Piaggesi, A.
    Vallini, V.
    Iacopi, E.
    Tedeschi, A.
    Scatena, A.
    Goretti, C.
    Rizzo, L.
    MINERVA CARDIOANGIOLOGICA, 2011, 59 (01): : 101 - 108